Comparative Efficacy of Interleukin Inhibitors and JAK Inhibitors in Moderate to Severe Plaque Psoriasis. (PubMed, Cureus) - Sep 11, 2026 - "Injectable interleukin inhibitors, such as risankizumab (Skyriz"
Journal • Review • Dermatology • Immunology • Psoriasis • IL17A • IL23A • TYK2
|
|
Alexandra Daily; Brittany Shectman; Kiarra Krulikowski; London Danchulis; Suzanne I Riskin
|